Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€53.18

€53.18

-0.150%
-0.08
-0.150%
€25.32
 
07:30 / Tradegate WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

Hims & Hers Health Inc. Stock

Hims & Hers Health Inc. shows a slight decrease today, losing -€0.080 (-0.150%) compared to yesterday.
Our community is currently high on Hims & Hers Health Inc. with 22 Buy predictions and 10 Sell predictions.
On the other hand, the target price of 25 € is below the current price of 53.18 € for Hims & Hers Health Inc., so the potential is actually -52.99%.
Our community identified positive and negative aspects for Hims & Hers Health Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Hims & Hers Health Inc. stock. On the other hand our users think that "Debt" could be a problem in the future.

Pros and Cons of Hims & Hers Health Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financial outlook for Hims & Hers Health (symbol: HIMS) presents an interesting tableau that mirrors the evolving landscape of the healthcare industry, particularly in the realm of telehealth and wellness services. At first glance, the company’s financials reflect both the potential for growth and the challenges that come with it. While the revenue growth shows promise, the profitability metrics raise some eyebrows. Here's a deeper dive into the pros and cons of the company's financial position.

1. Revenue Growth and Market Presence:

Hims & Hers has demonstrated impressive revenue growth, with a year-over-year quarterly revenue increase of approximately 45.8%. This growth trajectory signifies a strong market presence and an escalating demand for its digital health solutions. The total revenue stands at $959.4 million, highlighting the company’s ability to attract and retain a growing customer base in a competitive market.

Comments

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 9.25%
Target price 57.083
Change
Ends at 04.06.26

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $61.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 54.51%
Target price 54.009
Change
Ends at 06.05.26

Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

News

Hims & Hers Health Registered (A) Stock: Executives Sell Shares Amid Strong Growth
Hims & Hers Health Registered (A) Stock: Executives Sell Shares Amid Strong Growth

In a recent development, top executives at Hims & Hers Health executed significant stock sales in February 2025, with the CEO divesting shares worth approximately $10.23 million at prices ranging